Competing interests
G.M.O. is a consultant or advisor for AstraZeneca, Roche, Servier, MSD, Incyte, Eisai and Zymeworks, and declares Regeneron grant funding from Roche and AstraZeneca and travel funding AstraZeneca MSD, Roche, Novartis and Takeda. T.M. serves a consultant or advisory role for Amgen, Servier Incyte, Revolution Medicine, Sanofi, AstraZeneca, Taiho, Celgene and Eisai, and reports research funding from Celgene, AstraZeneca, BeiGene and Incyte and speaking funding from AstraZeneca, Incyte, Servier Roche and Eisai. P.L. declares no competing interests.
